Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LE H HUA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1215197892
CMS profile
1251558
Location
LAS VEGAS, NV

General Payments · PY2018–2024

$426,439.76

  • Reported across 452 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$28,741.54

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genentech USA, Inc. $7,766.31 6
GENZYME CORPORATION $5,527.55 2
TG THERAPEUTICS, INC. $4,728.00 8
EMD Serono, Inc. $3,266.43 5
NOVARTIS PHARMACEUTICALS CORPORATION $3,153.18 4
Acerta Pharma LLC $2,840.00 1
E.R. Squibb & Sons, L.L.C. $1,280.00 1
Amgen Inc. $166.09 5
ABBVIE INC. $13.98 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $83,481.96 94
PY2019 $104,083.05 139
PY2020 $75,490.27 51
PY2021 $47,986.90 26
PY2022 $51,576.19 65
PY2023 $35,079.85 44
PY2024 $28,741.54 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.98 03/11/2024 Food and Beverage Undisputed 01/23/2026 1103947388 CMS
Amgen Inc. $8.95 01/23/2024 Food and Beverage Undisputed 01/23/2026 1111602500 CMS
Amgen Inc. $9.30 03/18/2024 Food and Beverage Undisputed 01/23/2026 1111602502 CMS
Amgen Inc. $1.03 03/18/2024 Food and Beverage Undisputed 01/23/2026 1111602504 CMS
Amgen Inc. $118.71 04/15/2024 Food and Beverage Undisputed 01/23/2026 1111602508 CMS
Amgen Inc. $28.10 05/08/2024 Food and Beverage Undisputed 01/23/2026 1111602506 CMS
AstraZeneca Pharmaceuticals LP $2,840.00 09/17/2024 Consulting Fee Undisputed 01/23/2026 1104739583 CMS
E.R. Squibb & Sons, L.L.C. $1,280.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1101611950 CMS
EMD Serono, Inc. $140.65 02/29/2024 Food and Beverage Undisputed 01/23/2026 1120212052 CMS
EMD Serono, Inc. $2,780.00 03/04/2024 Consulting Fee Undisputed 01/23/2026 1120275262 CMS
EMD Serono, Inc. $115.54 04/16/2024 Food and Beverage Undisputed 01/23/2026 1120242165 CMS
EMD Serono, Inc. $110.91 09/20/2024 Food and Beverage Undisputed 01/23/2026 1120259492 CMS
EMD Serono, Inc. $119.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120274460 CMS
Genentech USA, Inc. $9.80 02/28/2024 Food and Beverage Undisputed 01/23/2026 1133052833 CMS
Genentech USA, Inc. $224.09 03/09/2024 Travel and Lodging Undisputed 01/23/2026 1133052837 CMS
Genentech USA, Inc. $101.69 03/09/2024 Food and Beverage Undisputed 01/23/2026 1133052841 CMS
Genentech USA, Inc. $6,210.00 03/09/2024 Consulting Fee Undisputed 01/23/2026 1133052845 CMS
Genentech USA, Inc. $185.73 09/17/2024 Food and Beverage Undisputed 01/23/2026 1133052829 CMS
Genentech USA, Inc. $1,035.00 10/16/2024 Consulting Fee Undisputed 01/23/2026 1133052849 CMS
GENZYME CORPORATION $123.55 08/13/2024 Food and Beverage Undisputed 01/23/2026 1139814081 CMS
GENZYME CORPORATION $5,404.00 08/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139814083 CMS
Novartis Pharmaceuticals Corporation $73.10 05/30/2024 Food and Beverage Undisputed 01/23/2026 1086783943 CMS
Novartis Pharmaceuticals Corporation $165.16 07/18/2024 Food and Beverage Undisputed 01/23/2026 1086783983 CMS
Novartis Pharmaceuticals Corporation $2,900.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 1086783985 CMS
Novartis Pharmaceuticals Corporation $14.92 09/19/2024 Food and Beverage Undisputed 01/23/2026 1086783975 CMS
TG Therapeutics, Inc. $115.00 01/18/2024 Food and Beverage Undisputed 01/23/2026 1136891048 CMS
TG Therapeutics, Inc. $23.50 04/18/2024 Food and Beverage Undisputed 01/23/2026 1136891098 CMS
TG Therapeutics, Inc. $30.63 05/31/2024 Food and Beverage Undisputed 01/23/2026 1136891076 CMS
TG Therapeutics, Inc. $16.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 1136891136 CMS
TG Therapeutics, Inc. $14.72 11/21/2024 Food and Beverage Undisputed 01/23/2026 1136891186 CMS
TG Therapeutics, Inc. $3,300.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1136891220 CMS
TG Therapeutics, Inc. $27.99 12/12/2024 Food and Beverage Undisputed 01/23/2026 1136891198 CMS
TG Therapeutics, Inc. $1,200.00 12/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1136891224 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.